pharmaphorum June 20, 2024
Phil Taylor

Dementia with Lewy bodies (DLB) may not be as well-known as other forms like Alzheimer’s but is just as devastating, so the discovery that commonly used drugs may reduce the risk of the disease is a beacon of hope for patients and their carers.

The main finding of the observational study, published in the journal Neurology, suggests that alpha-blocker drugs used to treat urinary symptoms caused by an enlarged prostate gland may reduce the risk of DLB, which accounts for between 3% and 7% of all dementia cases.

While observational studies only show an association between two factors and cannot show causality, the new data backs up an earlier finding that the drug class seems to reduce the risk of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech
Seattle biotech startup Bonum upgrades offices, expands team in its pursuit of cancer drugs
Public Health Matters Video: Walmart is Elevating Specialty Pharmacy Services and Enriching HIV Care
Demand for hospital pharmacists dips
Pfizer, Valneva inch closer to FDA approval of 1st Lyme disease vaccine
New Gene Therapy for Muscular Dystrophy May Facilitate Development of Others

Share This Article